Related Experiment Video
Updated: Feb 19, 2026

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
Finding the Missing Patients With Tuberculosis: Lessons Learned From Patient-Pathway Analyses in 5 Countries
Christy Hanson1,2, Mike Osberg3, Jessie Brown3
1Macalester College, St. Paul, M innesota.
Patient pathway analysis reveals significant gaps in tuberculosis diagnostic and treatment services, especially in private facilities. Tailored strategies are needed to reach "missing" tuberculosis patients by aligning services with where they seek care.
Area of Science:
- Global Health
- Infectious Diseases
- Public Health Policy
Background:
- Millions of tuberculosis (TB) cases remain unreported annually despite diagnostic and treatment advancements.
- Patient pathway analysis (PPA) is a tool to understand TB care-seeking behaviors and service availability.
- Identifying gaps in patient pathways is crucial for finding "missing" TB patients.
Purpose of the Study:
- To aggregate and compare patient pathway analyses from five countries: Kenya, Ethiopia, Indonesia, the Philippines, and Pakistan.
- To assess the alignment between patient TB care-seeking patterns and available diagnostic and treatment services.
- To identify opportunities for improving TB case detection and reporting.
Main Methods:
- Comparative analysis of patient pathway data from case studies in five diverse countries.
- Evaluation of care-seeking patterns at different facility levels (0, 1, 2) and sectors (public vs. private).
- Assessment of diagnostic (e.g., GeneXpert) and treatment capacity in relation to patient flow.
Main Results:
- Only 24% of TB patients initiated care at facilities with diagnostic capacity.
- Most patients (66%) sought care in private facilities with limited diagnostic capabilities.
- Significant subnational variations in care-seeking and service availability were observed.
- Tuberculosis treatment capacity correlated with diagnostic capacity, with limited GeneXpert availability in some areas.
Conclusions:
- Patient pathway analysis is a valuable tool for TB program planning and service delivery optimization.
- Closing the diagnostic gap and engaging the private sector are essential for patient-centered TB care.
- Differentiated, localized approaches are necessary due to substantial subnational differences in patient pathways.
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Principles of Disease Surveillance

